MISSISSAUGA, Ontario -- Bruker (Nasdaq: BRKR) today announced the acquisition of Tornado Spectral Systems Inc., a Canadian company specializing in process Raman instruments, primarily used in pharma and biotech quality control applications. Tornado, with over a decade of experience in innovative and industry-proven Raman solutions, will enhance Bruker’s biopharma PAT portfolio with its well-established products. Financial details [...]

Former Fortis Life Sciences CEO and private equity executive to drive expansion into clinical end markets and accelerate strategic biopharma collaborations  SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced the appointment of Brian Kim as Chief Executive Officer. With over two decades of experience in the life [...]

Investments into QDI to strengthen No. 1 industry position through profitable expansion into new geographic regions, market segments and enhanced product offerings QDI offers best-in-class insights for research and clinical customers performing molecular testing and analysis with access to new Omics knowledge bases and improved AI capabilities Portfolio improvements seek to alleviate informatics bottlenecks for [...]

AGD delivered ~86,000 whole genomes in 2023, including a unique diverse ancestry cohort Expanded pharma engagement enhances AGD's ability to develop multiomic datasets SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary [...]

Most comprehensive and ethnically diverse genomic coverage on a high throughput microarray delivers multi-disease and pharmacogenomic research analysis across global populations CARLSBAD, Calif. – Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more diverse representation of the human genome.1 To [...]

The 13th Acquisition Extends the Reach of its Multimodal Platform for Life Sciences Research & Development M-Star’s Computational Fluid Dynamics Software leverages GPU Acceleration to Quickly and Efficiently Simulate Complex Fluid Dynamics Environments Boston, MA – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the acquisition of M-Star, a leading computational fluid [...]

CARLSBAD, Calif. -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, today announced the release of ChromaCode Cloud 6.1, a major upgrade to its comprehensive analysis platform. This release marks significant progress in the development of ChromaCode's software, ensuring accessibility, affordability, and security in laboratory-based diagnostic solutions. ChromaCode Cloud is [...]

While the business of Biotage continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of Biotage AB with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new [...]

San Francisco, California – Biocare Medical, a leader in fully open automated instrumentation, announces a collaboration with Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology. This partnership brings together Biocare Medical’s expertise in automated bioimaging systems with MI’s suite of advanced HCR™ Products, setting a new standard in automated in situ hybridization (ISH) and [...]

SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic (Nasdaq: SLGC) at its Special Meeting of Stockholders. “We are pleased [...]